Seretide Diskus

Seretide Diskus: Effective Relief for Asthma and COPD

Seretide Diskus is a powerful inhaler designed to help manage asthma and chronic obstructive pulmonary disease (COPD). It combines the long-acting beta-2 agonist salmeterol with the inhaled corticosteroid fluticasone propionate to provide sustained relief and control symptoms.

How It Works

• Relaxing Airway Muscles: Salmeterol helps relax the muscles around the airways, making it easier to breathe.
• Reducing Inflammation: Fluticasone propionate reduces inflammation in the airways, which is crucial for long-term symptom control.

Indications

• Asthma: Seretide Diskus is indicated for the regular treatment of asthma, particularly in patients who require a combination product to manage their symptoms effectively.
• COPD: It is also used for the maintenance treatment of chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.

Dosage and Administration

• Inhalation Only: Seretide Diskus is for inhalation only and should be used regularly to maintain optimal benefit, even when symptoms are not present.
• Dose Titration: The dose should be titrated to the lowest effective dose to ensure the best control of symptoms.

Benefits

• Improved Lung Function: Regular use of Seretide Diskus can improve lung function and reduce the frequency and severity of exacerbations.
• Enhanced Quality of Life: By controlling symptoms and improving lung function, Seretide Diskus can significantly enhance the quality of life for patients with asthma and COPD.

Important Information

• Regular Use: Patients should be regularly reassessed by a doctor to ensure the strength of Seretide Diskus remains optimal and is only changed on medical advice.
• Convenience: The combination therapy offers increased convenience and possibly improved compliance, making it easier to manage your condition.

Seretide Diskus is a valuable tool in the management of obstructive lung diseases, providing sustained relief and improved quality of life for those who use it.